新規登録 | ログイン | FAQ      [?] 

Cancer Gene Therapy

最近発刊の雑誌の目次より: Cancer Gene Therapy © Nature Publishing Group
  • Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth
    Cancer Gene Therapy, Vol. aop, No. current.
  • Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by R Frade, N Rousselet, D Jean
  • Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Gan, J Gu, X Cai, J Hu, XY Liu, X Zhao
  • Conditioned medium from Ad-IFN-α-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect
    Cancer Gene Therapy, Vol. aop, No. current.
    by X Zhang, L Dong, E Chapman, WF Benedict
  • Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects
    Cancer Gene Therapy, Vol. aop, No. current.
    by HT Jin, JI Youn, SY Choi, SH Seo, SH Park, MY Song, SH Yang, YC Sung
  • Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD
    Cancer Gene Therapy, Vol. aop, No. current.
    by JI Youn, SH Park, HT Jin, CG Lee, SH Seo, MY Song, CW Lee, YC Sung
  • E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2
    Cancer Gene Therapy, Vol. aop, No. current.
    by DJ Mitchell, RF Minchin
  • Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Cottin, K Ghani, M Caruso
  • ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice
    Cancer Gene Therapy, Vol. aop, No. current.
  • Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Song, Z Dong, T Jin, MG Mantellini, G Núñez, JE Nör
  • Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis
    Cancer Gene Therapy, Vol. aop, No. current.
    by RL Novak, AC Phillips
  • Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model
    Cancer Gene Therapy, Vol. aop, No. current.
  • Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication
    Cancer Gene Therapy, Vol. aop, No. current.
    by YY Mahller, B Sakthivel, WH Baird, BJ Aronow, YH Hsu, TP Cripe, R Mehrian-Shai
  • HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by IAW Ho, KYW Chan, L Miao, WSN Shim, CM Guo, P Cheang, KM Hui, PYP Lam
  • Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo
    Cancer Gene Therapy, Vol. aop, No. current.
    by DB Xiang, ZT Chen, D Wang, MX Li, JY Xie, YS Zhang, Y Qing, ZP Li, J Xie
  • Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
    Cancer Gene Therapy, Vol. aop, No. current.
  • JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Hu, W Hofstetter, W Guo, H Li, A Pataer, HH Peng, ZS Guo, DL Bartlett, A Lin, SG Swisher, B Fang
  • Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Gao, SSM Ng, DHW Chau, H Yao, C Yang, K Man, PT Huang, C Huang, JJ Huang, HF Kung, MC Lin
  • Dual induction of PKR with E2F-1 and IFN-α to enhance gene therapy against hepatocellular carcinoma
    Cancer Gene Therapy, Vol. aop, No. current.
    by V Roh, A Laemmle, U Von Holzen, D Stroka, JF Dufour, KK Hunt, D Candinas, SA Vorburger
  • Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck
    Cancer Gene Therapy, Vol. aop, No. current.
  • Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model
    Cancer Gene Therapy, Vol. aop, No. current.
    by F Solly, R Fish, B Simard, N Bolle, E Kruithof, B Polack, G Pernod
  • Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by KF Hsu, CL Wu, SC Huang, JL Hsieh, YS Huang, YF Chen, MR Shen, WJ Chung, CY Chou, AL Shiau
  • Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by RA Abela, J Qian, L Xu, TS Lawrence, M Zhang
  • A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate
    Cancer Gene Therapy, Vol. aop, No. current.
    by Kraljevic S Pavelic, T Cacev, M Kralj
  • Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts
    Cancer Gene Therapy, Vol. aop, No. current.
    by Q Leng, P Scaria, P Lu, MC Woodle, AJ Mixson
  • In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method
    Cancer Gene Therapy, Vol. aop, No. current.
    by SS Yu, I Nukaya, T Enoki, E Chatani, A Kato, Y Goto, K Dan, M Sasaki, K Tomita, M Tanabe, H Chono, J Mineno, I Kato
  • Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors
    Cancer Gene Therapy, Vol. aop, No. current.
    by W Fu, H Lan, S Li, X Han, T Gao, D Ren
  • Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Sas, T Chan, A Sami, A El-Gayed, J Xiang
  • Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect
    Cancer Gene Therapy, Vol. aop, No. current.
  • Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma
    Cancer Gene Therapy, Vol. aop, No. current.
  • A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by TT Poulsen, N Pedersen, H Juel, HS Poulsen
  • Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by J Hao, X Song, B Song, Y Liu, L Wei, X Wang, J Yu
  • Targeting sodium/iodide symporter gene expression for estrogen-regulated imaging and therapy in breast cancer
    Cancer Gene Therapy, Vol. aop, No. current.
  • The ERBB3 receptor in cancer and cancer gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
  • Effects of DNAzymes targeting Aurora kinase A on the growth of human prostate cancer
    Cancer Gene Therapy, Vol. aop, No. current.
    by Y Qu, L Zhang, M Mao, F Zhao, X Huang, C Yang, Y Xiong, D Mu
  • Tumor-targeting prodrug-activating bacteria for cancer therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by CM Cheng, YL Lu, KH Chuang, WC Hung, J Shiea, YC Su, CH Kao, BM Chen, S Roffler, TL Cheng
  • Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
    by M Guan, V Tripathi, X Zhou, NC Popescu
  • Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
    Cancer Gene Therapy, Vol. aop, No. current.
    by AW Tong, J Nemunaitis
  • In vivo restoration of RhoB expression leads to ovarian tumor regression
    Cancer Gene Therapy, Vol. aop, No. current.
    by B Couderc, A Pradines, A Rafii, M Golzio, A Deviers, C Allal, D Berg, M Penary, J Teissie, G Favre
  • Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells
    Cancer Gene Therapy, Vol. aop, No. current.
    by R Wang, F Lin, X Wang, P Gao, K Dong, AM Zou, SY Cheng, SH Wei, HZ Zhang
  • A cancer terminator virus eradicates both primary and distant human melanomas
    Cancer Gene Therapy, Vol. aop, No. current.
    by D Sarkar, Z-Z Su, ES Park, N Vozhilla, P Dent, DT Curiel, PB Fisher
  • Expression-targeted gene therapy for the treatment of transitional cell carcinoma
    Cancer Gene Therapy, Vol. aop, No. current.
    by X Zhang, A Atala, WT Godbey
  • Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Shamimi-Noori, WS Yeow, MF Ziauddin, H Xin, TLN Tran, J Xie, A Loehfelm, P Patel, J Yang, DS Schrump, BL Fang, DM Nguyen
  • Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes
    Cancer Gene Therapy, Vol. aop, No. current.
    by KS Kim, YK Lee, JS Kim, KH Koo, HJ Hong, YS Park
  • Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy
    Cancer Gene Therapy, Vol. aop, No. current.
  • Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-rasLA1 mice
    Cancer Gene Therapy, Vol. aop, No. current.
    by H Jin, CX Xu, HW Kim, YS Chung, JY Shin, SH Chang, SJ Park, ES Lee, SK Hwang, JT Kwon, A Minai-Tehrani, M Woo, MS Noh, HJ Youn, DY Kim, BI Yoon, KH Lee, TH Kim, CS Cho, MH Cho
    posted by 1 person sivadurga
  • Genetically engineered T cells expressing a HER2-specific chimeric receptor mediate antigen-specific tumor regression
    Cancer Gene Therapy, Vol. aop, No. current.
    by S Li, J Yang, FA Urban, JN Macgregor, DPM Hughes, AE Chang, KT Mcdonagh, Q Li
  • Synergistic effect of 15-lipoxygenase 2 and radiation in killing head-and-neck cancer
    Cancer Gene Therapy, Vol. aop, No. current.
    by Q Yang, Y Feng, CJ Schultz, XA Li, H Wu, D Wang
  • Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model
    Cancer Gene Therapy, Vol. aop, No. current.
    by P Huang, M Watanabe, H Kaku, Y Kashiwakura, J Chen, T Saika, Y Nasu, T Fujiwara, Y Urata, H Kumon
  • Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human
    Cancer Gene Therapy, Vol. aop, No. current.
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/cancer-gene-therapy-aop

    Result page: 1 2 3 4 5 6 7 8 Next RIS BibTeX RSS
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.